Unckell F, Streeck R E, Sapp M
Institute for Medical Microbiology and Hygiene, University of Mainz, Germany.
J Virol. 1997 Apr;71(4):2934-9. doi: 10.1128/JVI.71.4.2934-2939.1997.
Since human papillomaviruses (HPV) cannot be propagated in cell culture, the generation of infectious virions in vitro is a highly desirable goal. Here we report that pseudovirions can be generated by the assembly of virus-like particles (VLPs) in COS-7 cells containing multiple copies of a marker plasmid. Using recombinant vaccinia viruses, we have obtained spherical VLPs of HPV type 33 (HPV-33) which fractionate into heavy and light VLPs in cesium chloride density gradients. VLPs in the heavy fraction (1.31 g/cm3) carry the plasmid in DNase-resistant form and are capable of transferring the genetic marker located on the plasmid to COS-7 cells in a DNase-resistant way (pseudoinfection). The minor capsid protein L2 is not required for encapsidation but is essential for efficient pseudoinfection. Antiserum to HPV-33 VLPs inhibits VLP-mediated DNA transfer with high efficiency. Antisera to VLPs of HPV-18 and HPV-16 are not neutralizing, although the HPV-16 antiserum exhibited some cross-reactivity with HPV-33 VLPs in an enzyme-linked immunosorbent assay. In a cell binding assay, the titer of the HPV-33 VLP antiserum was 1:200 compared to the neutralization titer of 1:10(5). This indicates that neutralization is essentially due to the inhibition of cellular processes after VLP binding to cells. The encapsidation of marker plasmids into VLPs provides a sensitive and fast assay for the evaluation of neutralizing potentials of antisera against papillomavirus infections.
由于人乳头瘤病毒(HPV)无法在细胞培养中增殖,因此在体外产生感染性病毒粒子是一个非常理想的目标。在此我们报告,在含有多拷贝标记质粒的COS-7细胞中,通过病毒样颗粒(VLP)的组装可以产生假病毒粒子。利用重组痘苗病毒,我们获得了33型人乳头瘤病毒(HPV-33)的球形VLP,其在氯化铯密度梯度中可分为重VLP和轻VLP。重组分(1.31 g/cm³)中的VLP以抗DNA酶的形式携带质粒,并且能够以抗DNA酶的方式将位于质粒上的遗传标记转移至COS-7细胞(假感染)。次要衣壳蛋白L2对于衣壳化不是必需的,但对于有效的假感染至关重要。HPV-33 VLP抗血清可高效抑制VLP介导的DNA转移。HPV-18和HPV-16 VLP的抗血清没有中和作用,尽管在酶联免疫吸附试验中HPV-16抗血清与HPV-33 VLP表现出一些交叉反应性。在细胞结合试验中,HPV-33 VLP抗血清的效价为1:200,而中和效价为1:10⁵。这表明中和作用主要是由于VLP与细胞结合后对细胞过程的抑制。将标记质粒包装到VLP中为评估抗乳头瘤病毒感染血清的中和潜力提供了一种灵敏且快速的检测方法。